Method For Reducing Levels Of Disease Associated Proteins

  • Published: Dec 18, 2008
  • Earliest Priority: May 03 2005
  • Family: 10
  • Cited Works: 3
  • Cited by: 0
  • Cites: 2
  • Additional Info: Cited Works Full text
Abstract

The subject invention concerns the reduction of protein aggregation in the neurons of a mammal through the use of a ketogenic treatment such as a ketogenic diet, a physical training regimen and/or administration of agents to increase fatty acid oxidation. Such ketogenic treatment can be useful in the reduction of certain aggregates including amyloid ß peptide, polyglutamine containing huntintin protein, polyglutamine containing androgen receptor, polyglutamine containing atrophin-1, polyglutamine containing ataxins, a-synclein, prion protein, tau and superoxide dismutase 1 (SOD1).


Claims

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Dec 18, 2008
  • Application: Mar 8, 2006
    WO US 2006/0008668 W
  • Priority: May 3, 2005
    US US 12370605 A

Sign in to the Lens

Feedback